BioSpace News Archive

Policy

San Francisco, New York Declare Local Health Emergencies Over Monkeypox

The measures will allow San Francisco and New York to coordinate efforts across different agencies and raise the public’s awareness to curb the spread of monkeypox.

July 29, 2022
·
2 min read
·
Tristan Manalac
Drug Development

Clinical Catch-Up: Seagen, Astellas, SOTIO & More

InMed updated its INM-755 for patients with epidermolysis bullosa, Seagen and Astellas announced positive topline results for Padcev with Merck’s Keytruda, and more.

July 29, 2022
·
4 min read
·
Mark Terry
Drug Development

FDA Action Alert: Coherus, Sanofi and Regeneron, Acadia, Myovant and Pfizer

The end of July is busy for the FDA, with Coherus, Sanofi, Acadia, Myovant and Pfizer having PDUFA dates filling the calendar. Here’s a look.

July 29, 2022
·
3 min read
·
Mark Terry
Drug Development

A Rare Miss for BMS: Phase III Kidney Cancer Trial Fails to Hit Endpoint

Bristol Myers Squibb’s Opdivo (nivolumab) and Yervoy (ipilimumab) as an adjuvant treatment for localized renal cell carcinoma (RCC) failed to hit the primary endpoint.

July 29, 2022
·
3 min read
·
Mark Terry
Employer Resources

How to Handle Layoffs as an Employer

Considering biotech and pharma companies are not immune to the pressures and situations that lead to layoffs, it might be time to learn how to handle layoffs as an employer.

July 29, 2022
·
5 min read
·
Kaley Lefevre
With Some Help, Small Canadian Biotech Could Challenge Roche’s Hold in Stroke Treatment

NervGen showed that its proprietary drug NVG-291-R, could repair the nervous system after a stroke in rodents —even when it was given seven days after the episode.

July 29, 2022
·
3 min read
·
Tristan Manalac
Drug Development

ImmunityBio’s Bladder Cancer Immunotherapy BLA gets FDA Nod

The BLA is for the use of the drug N-803 with BCG to treat patients with BCG-unresponsive non-muscle-invasive bladder cancer carcinoma with or without Ta or T1 disease.

July 29, 2022
·
3 min read
·
Mark Terry
Taiwan Startup PrecisemAb Continues Progress Towards Vision of Safest Antibody Treatment With No Side Effects

PrecisemAb Biotech, a biotechnology research company based in Kaohsiung, Taiwan, continues to stay true to its vision of enhancing antibody drugs by reducing side effects through the patented Universal Antibody Lock technology.

July 29, 2022
·
2 min read
Hemophilia Gene Therapy Market Insights and Emerging Trends by 2030

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global hemophilia gene therapy market is predicted to increase at a stellar pace in the years to follow.

July 29, 2022
·
5 min read
Healthcare EDI Market Study Offering Deep Insight Related to Growth Trends Until 2031

Wilmington, Delaware, United States, Transparency Market Research Inc.: The players in the global healthcare EDI market offer various solutions as well as services to healthcare providers as well as healthcare payers.

July 29, 2022
·
6 min read